drug delivery platform development

Analytomix LLC is a biomedical company whose mission is to devise smart molecules for diagnostic tests and state of the art cancer treatment. It has developed a modular platform called AptaLinx for precision cancer drug delivery that uses the tumor itself as the trigger for drug release, anchored by FDA-approved antibodies that bind to specific cancer cell markers.

Read more

biomedical researchprecision cancer drug delivery

EnduRx Pharmaceuticals Inc. is a virtual, pre-clinical company developing a peptide-directed polymeric nanoparticle drug delivery platform and therapeutics for hard-to-treat solid tumors and selected other indications. Its candidates are designed to achieve tumor-specific delivery of active pharmaceutical ingredients while avoiding healthy tissue. The company is led by experienced life science executives and scientists and utilizes resources across the US, with a corporate office in Tucson, AZ.

Read more

nanoparticle therapeuticspre-clinical research